Prediabetes and diabetes can cause ongoing damage (such as vision loss) before people notice symptoms. Screening can save lives and improve outcomes. For support after screening, Verily Lightpath makes it easy for employers and health plans to offer data-driven, AI-enabled, personalized care to team members with chronic conditions including diabetes.
Our recent $300M funding, led by Series X Capital and including Alphabet Inc., is a powerful validation of our vision and a direct accelerator for the Verily Pre platform. As our CEO Stephen Gillett discusses in his recent blog, we will be focusing on: • Expanding Verily Pre capabilities with the latest technology • Launching new agents for both the Pre Data & AI Exchange and our consumer-facing Verily Me app • Driving new commercial opportunities globally • Expanding tools for clinical researchers and drug development Pre unifies complex health data into actionable intelligence, empowering the next generation of AI-enabled care that is more predictable, preventative, and precise.
Digital health is undergoing a radical shift. Conversations are moving from "What’s wrong?" to "Here is what we’ve found and what you should do next." This was the focus of our SXSW session: "How AI is Enabling A Radical Shift in Understanding Your Health." With an engaged audience, Dr. Vindell Washington, John Gerzema and Arundhati Parmar discussed three critical insights that are driving the future of digital health: 1️⃣ The key to valuable health AI is context, not a blank cursor. We are moving beyond "fill in the blank" interactions by building suggestions into the experience and providing the "prompts" users need to script their own health journey. 2️⃣ By putting data into context, we can identify gaps in care and start personalized conversations based on a user's medical history. This process turns raw health records into a personalized roadmap for care. 3️⃣ The dialogue in digital health is changing, building a bridge between raw health data and actionable expectations. "Health AI will evolve like any other great wellness tool. Users will arrive with a specific set of needs and jobs to be done, and we intend to be ready to support them," said Dr. Washington. Thank you to everyone who joined us in Austin! Let's continue building the future of health, together.
Big news! We've secured a $300M funding round led by Series X Capital, with additional backing from Alphabet Inc., UCHealth, and the University of Colorado Anschutz. This milestone will advance the next phase of our precision health strategy. To mark this new chapter, we are officially moving forward as “Verily Health”, with a focus on accelerating our AI roadmap, including our health data platform, Verily Pre. Pre unifies siloed, complex and unstructured health data, enabling organizations across the healthcare ecosystem to transform their data into actionable intelligence. This transformation can speed vital drug development and deliver the next generation of care that is more personal, predictive, and precise, improving quality of life, reducing clinician burden and closing care gaps. We thank our investors for their partnership and support in bringing clinically-informed, AI-driven solutions to advance personalized care.
We're excited to continue expanding our collaboration with NVIDIA to enhance precision health! Verily is testing the open source Nemotron model family to power the next generation of our digital health AI tools. In healthcare, open models matter; they give organizations like ours the ability to fine-tune for clinical precision, maintain full transparency, and keep patient data secure within our own infrastructure. We're starting with our AI companion, Violet, available via the Verily Me app where open architecture can deliver lower latency and greater accuracy for the people who depend on it!
As employers face cost pressures and complexity, they are looking to new technologies to help them deliver an amazing member experience. Verily Chief Product Officer Myoung Cha will speak at The Conference Board's Employee Health Care Conference in NYC on how emerging AI-powered solutions are helping employers address this challenge and deliver better outcomes. He'll join Michelle Acciavatti and Dr. Jeff Levin-Scherz of WTW for the session: Navigating the New Health Care Frontier: Emerging Trends in Supporting the Member Journey on March 18 at 8:00 AM ET.
The Verily team wrapped up a great week at HIMSS26. Thank you for stopping by our booth to connect with us! At the event, we announced our collaboration with Samsung to accelerate clinical research. Galaxy Watch sensor data will be integrated into our precision health platform, Verily Pre, to unlock advanced insights for study sponsors.
Say hi to the new Verily Me 👋 Today at SXSW 2026, we announced new features and the general availability of our consumer health app, Verily Me, following a successful beta phase. Verily Me is designed to close gaps in care by enabling access to personalized health recommendations from licensed providers based on available medical history across clinicians and health systems. It includes “Violet,” the AI companion, that provides 24/7 support to help individuals interpret their health data and make sense of their health. The new features offer a safe and private space to check symptoms: ✨ Personalized health recommendation refreshes from licensed clinicians ✨ AI-guided symptom navigation with Violet ✨ Deeper nutrition insight
Better evidence makes precision health possible. We're excited to announce a new collaboration that brings together Samsung Galaxy Watch with Verily’s precision health platform, Pre, to create an integrated solution for generating evidence and monitoring real-world populations. Together, we’ll accelerate research for life sciences and government customers by combining advanced health analytics with consumer-grade wearable data. This work builds on our long history of leading the design and verification of digital measures across various therapeutic areas, including the development of advanced AI algorithms for Parkinson's disease that established the state of the art in accuracy, reliability, and safety as published in peer-reviewed journal articles. “The use of consumer-friendly devices in clinical research makes it easier for participants to engage in studies, while enabling sponsors to use advanced biomarkers to generate high quality data,” said Scott Burke, Chief Technology Officer at Verily. “This collaboration realizes our vision to integrate health research into everyday life, in order to generate better evidence and make precision health possible for all.”
Verily and Salesforce are joining forces to bring the power of multimodal data and AI to the forefront of patient care. Verily integrates and enriches everything from wearables to nutrition trackers and lab tests to power more predictive, preventative, and precise care. Bringing this deep clinical and lifestyle intelligence will enable Agentforce Health to activate multimodal data to personalize health experiences, accelerate research, and deliver more tailored care. We are excited by the potential to advance new solutions and AI workflows to help providers unlock value and improve patient care.
